Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel P Dickson

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
American Journal of Human Genetics|September 4, 2012
Prioritizing genetic variants for causality on the basis of preferential linkage disequilibriumQianqian Zhu, Dongliang Ge, Erin L Heinzen, et al.
Neurology and Therapy|June 15, 2025
Development and Validation of PARCOMS Composite Scales for Assessing Disease Progression and Treatment Effects in Parkinson's DiseaseGil L'Italien, Basia Rogula, Lauren Powell, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 8, 2021
GenoRisk: A polygenic risk score for Alzheimer's diseaseSamuel P Dickson, Suzanne B Hendrix, Bruce L Brown, et al.
Parkinsonism & Related Disorders|October 17, 2025
Development of composite scales for assessing disease progression and treatment effects among patients with Parkinson's disease in a clinical trial settingGil L'Italien, Basia Rogula, Lauren C Powell, et al.
Ebiomedicine|July 1, 2023
Safety, tolerability, immunogenicity, and efficacy of UB-311 in participants with mild Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase 2a studyHui Jing Yu, Samuel P Dickson, Pei-Ning Wang, et al.
Malaria Journal|December 8, 2016
Cytochrome P450 2D-mediated metabolism is not necessary for tafenoquine and primaquine to eradicate the erythrocytic stages of Plasmodium bergheiErin E Milner, Jonathan Berman, Diana Caridha, et al.
Bioinformatics (Oxford, England)|June 1, 2011
SVA: software for annotating and visualizing sequenced human genomesDongliang Ge, Elizabeth K Ruzzo, Kevin V Shianna, et al.
Journal of Clinical Pharmacology|November 21, 2024
Results of the ACTION-Galactosemia Kids Study to Evaluate the Effects of Govorestat in Pediatric Patients with Classic GalactosemiaEvan Bailey, Han Phan, Ayesha Ahmad, et al.
BMC Microbiology|November 8, 2015
Characterization of the murine macrophage response to infection with virulent and avirulent Burkholderia speciesChih-Yuan Chiang, Ricky L Ulrich, Melanie P Ulrich, et al.
Cell Host & Microbe|May 21, 2009
The Duffy antigen receptor for chemokines null promoter variant does not influence HIV-1 acquisition or disease progressionNicole M Walley, Boris Julg, Samuel P Dickson, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
American Journal of Human Genetics|September 4, 2012
Prioritizing genetic variants for causality on the basis of preferential linkage disequilibriumQianqian Zhu, Dongliang Ge, Erin L Heinzen, et al.
Neurology and Therapy|June 15, 2025
Development and Validation of PARCOMS Composite Scales for Assessing Disease Progression and Treatment Effects in Parkinson's DiseaseGil L'Italien, Basia Rogula, Lauren Powell, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 8, 2021
GenoRisk: A polygenic risk score for Alzheimer's diseaseSamuel P Dickson, Suzanne B Hendrix, Bruce L Brown, et al.
Parkinsonism & Related Disorders|October 17, 2025
Development of composite scales for assessing disease progression and treatment effects among patients with Parkinson's disease in a clinical trial settingGil L'Italien, Basia Rogula, Lauren C Powell, et al.
Ebiomedicine|July 1, 2023
Safety, tolerability, immunogenicity, and efficacy of UB-311 in participants with mild Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase 2a studyHui Jing Yu, Samuel P Dickson, Pei-Ning Wang, et al.
Malaria Journal|December 8, 2016
Cytochrome P450 2D-mediated metabolism is not necessary for tafenoquine and primaquine to eradicate the erythrocytic stages of Plasmodium bergheiErin E Milner, Jonathan Berman, Diana Caridha, et al.
Bioinformatics (Oxford, England)|June 1, 2011
SVA: software for annotating and visualizing sequenced human genomesDongliang Ge, Elizabeth K Ruzzo, Kevin V Shianna, et al.
Journal of Clinical Pharmacology|November 21, 2024
Results of the ACTION-Galactosemia Kids Study to Evaluate the Effects of Govorestat in Pediatric Patients with Classic GalactosemiaEvan Bailey, Han Phan, Ayesha Ahmad, et al.
BMC Microbiology|November 8, 2015
Characterization of the murine macrophage response to infection with virulent and avirulent Burkholderia speciesChih-Yuan Chiang, Ricky L Ulrich, Melanie P Ulrich, et al.
Cell Host & Microbe|May 21, 2009
The Duffy antigen receptor for chemokines null promoter variant does not influence HIV-1 acquisition or disease progressionNicole M Walley, Boris Julg, Samuel P Dickson, et al.
Pageof 4